Home GSK, Prosensa muscular dystrophy drug misses study goal
 

Keywords :   


GSK, Prosensa muscular dystrophy drug misses study goal

2013-09-20 17:19:30| Biotech - Topix.net

An experimental drug for Duchenne muscular dystrophy from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stage clinical trial, sending shares in Prosensa tumbling 75 percent in pre-market trade.

Tags: study goal drug muscular

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.11 DVD-BOX5
15.11 100
15.11NIKE X (27)
15.11 MEMORIA8 HOOD Towel
15.1119HGLEFT
15.11
15.11X-PLUS
15.11 BoU CD
More »